Chairman,
Ronnie A Hershman, MD., FACC An active practicing New York Cardiologist with over two decades of experience, Dr. Hershman is American Board Certified in Internal Medicine and Cardiology, and President of Long Island Cardiac Care, LLC. He founded and served as Managing Director of Integrated Cardiovascular Therapeutics ICT, Woodbury, NY. Dr. Hershman earned his MD degree from Mount Sinai School of Medicine. He is also recognized as a successful entrepreneur, and has been involved in life science investing, evaluation and consulting. He currently serves on the boards of several companies including TheraVitae, Inc., InMotion, Inc. and Optivasive Ltd., as well as serving as an advisor to Life Sciences Opportunities Fund, LP, a $100 million,a late-stage life science venture capital company.
President and Executive Director
Sabina Glozman, PhD, MBA Dr. Glozman returns to SoluBest after managing Biological Industries Ltd. since 2008. Previously, Dr. Glozman served as CEO at Vecta Pharmaceuticals and VP Business Development at Protalix, among other companies. She has also founded a number of life-science start-up ventures, including Accelta Ltd., a spin-off of Technion and leading transfer technology projects from Ben Gurion University and the National Institute of Biotechnology and University Haifa. Dr. Glozman is a graduate of the Hebrew University in Jerusalem and has earned her PhD in the Weizmann Institute of Science, in the Neurochemistry Department. She has also specialized in Post-Doctorate in Membrane Biology and Cancer Research.
Head of R&D and COO
Galia Temstin-Krayz, PhD. Galia directs SoluBest's Formulation R&D, its analytical method development, process optimization and scale-up. She earned her PhD in Organic and Material Chemistry from Ben Gurion University in Beer Sheva, Israel and has specialized in self assembly nano-delivery systems from Division of Material Chemistry, at the Chemical Department, in the University of Toronto, Canada. She has both academic and industrial experience in organic synthesis and process development of APIs in Perrigo (Chemagis, Israel).
